Mohammad S. Rostami

Array ( [id] => 4305156 [patent_doc_number] => 06251945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Pharmaceutical mixture comprising a combination of a profen and other active compounds' [patent_app_type] => 1 [patent_app_number] => 9/245112 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4200 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251945.pdf [firstpage_image] =>[orig_patent_app_number] => 245112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252465 [patent_doc_number] => 06207685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Therapeutic application of a thienycyclohexylamine derivative' [patent_app_type] => 1 [patent_app_number] => 9/180384 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3819 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207685.pdf [firstpage_image] =>[orig_patent_app_number] => 180384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409398 [patent_doc_number] => 06239172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Formulations for treating disease and methods of using same' [patent_app_type] => 1 [patent_app_number] => 9/226580 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5018 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239172.pdf [firstpage_image] =>[orig_patent_app_number] => 226580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252691 [patent_doc_number] => 06207700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Amide derivatives for antiangiogenic and/or antitumorigenic use' [patent_app_type] => 1 [patent_app_number] => 9/226693 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12939 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207700.pdf [firstpage_image] =>[orig_patent_app_number] => 226693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305086 [patent_doc_number] => 06251941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Use of inhaled retinoids in the prevention of cancer' [patent_app_type] => 1 [patent_app_number] => 9/171478 [patent_app_country] => US [patent_app_date] => 1998-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2662 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251941.pdf [firstpage_image] =>[orig_patent_app_number] => 171478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133476 [patent_doc_number] => 06147107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells' [patent_app_type] => 1 [patent_app_number] => 9/203342 [patent_app_country] => US [patent_app_date] => 1998-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 7559 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147107.pdf [firstpage_image] =>[orig_patent_app_number] => 203342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216508 [patent_doc_number] => 06110917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use' [patent_app_type] => 1 [patent_app_number] => 9/202539 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2801 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110917.pdf [firstpage_image] =>[orig_patent_app_number] => 202539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495721 [patent_doc_number] => 06403641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-11 [patent_title] => 'Therapeutic agents' [patent_app_type] => B2 [patent_app_number] => 09/212249 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3662 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403641.pdf [firstpage_image] =>[orig_patent_app_number] => 09212249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304152 [patent_doc_number] => 06251883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Methods for preparation and use of 1.alpha.,24(S)-dihydroxy vitamin D2' [patent_app_type] => 1 [patent_app_number] => 9/211991 [patent_app_country] => US [patent_app_date] => 1998-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12081 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251883.pdf [firstpage_image] =>[orig_patent_app_number] => 211991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4155471 [patent_doc_number] => 06107296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Neuroprotective use of triazolo-pyridazine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/206416 [patent_app_country] => US [patent_app_date] => 1998-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11236 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107296.pdf [firstpage_image] =>[orig_patent_app_number] => 206416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4130490 [patent_doc_number] => 06127580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Process for the preparation of substituted anthraquinones' [patent_app_type] => 1 [patent_app_number] => 9/200936 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3259 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127580.pdf [firstpage_image] =>[orig_patent_app_number] => 200936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304649 [patent_doc_number] => 06187779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives' [patent_app_type] => 1 [patent_app_number] => 9/197311 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7721 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 442 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187779.pdf [firstpage_image] =>[orig_patent_app_number] => 197311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235305 [patent_doc_number] => 06117897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => '1/2 sulfate of a [(S) -1- [(S) -2- [(trans-4- aminocyclohexylmethyl) carbamoyl]pyrrolidine-1-carbonyl]- 2-isopropylthio-2-methylpropyl]carbamic acid propyl ester' [patent_app_type] => 1 [patent_app_number] => 9/195219 [patent_app_country] => US [patent_app_date] => 1998-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4830 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117897.pdf [firstpage_image] =>[orig_patent_app_number] => 195219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3951153 [patent_doc_number] => 05977417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Preparation of 1,4-butanediol' [patent_app_type] => 1 [patent_app_number] => 9/192484 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2441 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977417.pdf [firstpage_image] =>[orig_patent_app_number] => 192484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065627 [patent_doc_number] => 20010044470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'METHOD TO CONTROL ANIMAL ECTO-PARASITES' [patent_app_type] => new [patent_app_number] => 09/192499 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3051 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044470.pdf [firstpage_image] =>[orig_patent_app_number] => 09192499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292600 [patent_doc_number] => 06235776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Method for treating a patient with neoplasia by treatment with a paclitaxel derivative' [patent_app_type] => 1 [patent_app_number] => 9/190637 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 9608 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235776.pdf [firstpage_image] =>[orig_patent_app_number] => 190637 [rel_patent_id] =>[rel_patent_doc_number] =>)